Monte Rosa Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLUE and other ETFs, options, and stocks.About GLUE
Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.
CEOMarkus Warmuth
CEOMarkus Warmuth
Employees134
Employees134
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2019
Founded2019
Employees134
Employees134
GLUE Key Statistics
Market cap1.52B
Market cap1.52B
Price-Earnings ratio52.42
Price-Earnings ratio52.42
Dividend yield—
Dividend yield—
Average volume3.06M
Average volume3.06M
High today$25.25
High today$25.25
Low today$17.50
Low today$17.50
Open price$21.99
Open price$21.99
Volume23.18M
Volume23.18M
52 Week high$25.25
52 Week high$25.25
52 Week low$3.50
52 Week low$3.50
Stock Snapshot
The current Monte Rosa Therapeutics(GLUE) stock price is $23.11, with a market capitalization of 1.52B. The stock trades at a price-to-earnings (P/E) ratio of 52.42.
On 2026-01-07, Monte Rosa Therapeutics(GLUE) stock traded between a low of $17.50 and a high of $25.25. Shares are currently priced at $23.11, which is +32.1% above the low and -8.5% below the high.
Monte Rosa Therapeutics(GLUE) shares are trading with a volume of 23.18M, against a daily average of 3.06M.
During the past year, Monte Rosa Therapeutics(GLUE) stock moved between $3.50 at its lowest and $25.25 at its peak.
During the past year, Monte Rosa Therapeutics(GLUE) stock moved between $3.50 at its lowest and $25.25 at its peak.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own GLUE. This list is generated using Robinhood data, and it’s not a recommendation.